(1)
Roundtable Discussion: Navigating Challenging Treatment Decisions in Relapsed and Refractory Multiple Myeloma (RRMM). Can Hematol Today 2023, 2 (s07), 2–5. https://doi.org/10.58931/cht.2023.2s0736.